News

By Stephanie Brown HealthDay ReporterMONDAY, Aug. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced ...
The U.S. Food and Drug Administration on Monday named Sean Keveney as its new chief counsel, placing him in charge of ...
The supplemental New Drug Application is supported by data from the Phase II TRANSCEND FL trial (NCT04245839), which showed ...
The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
The U.S. Food and Drug Administration (FDA) has elevated a nationwide recall covering 64,800 pounds (that’s 1,800 cases) of ...
The FDA 's classification of the Queen Bee Gardens recall as Class II signals a moderate health risk, indicating that use or ...
Vertex Pharmaceuticals Inc. shares fell 15% after an experimental pain drug failed to benefit patients after surgery and US ...
Stealth BioTherapeutics, which has been developing a rare disease drug, said it is making contingency plans to close the ...
Whoop is betting on political connections and wellness claims to keep its blood pressure monitoring feature, despite FDA ...
US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...